Gadolinium silicate-coated porous silicon nanoparticles as an MRI contrast agent and drug delivery carrier

Xiao, 2016, MRI contrast agents: classification and application (Review), Int. J. Mol. Med., 38, 1319, 10.3892/ijmm.2016.2744 Lundervold, 2019, An overview of deep learning in medical imaging focusing on MRI, Z. Med. Phys., 29, 102, 10.1016/j.zemedi.2018.11.002 Hartwig, 2009, Biological effects and safety in magnetic resonance imaging: a review, Int. J. Environ. Res. Publ. Health, 6, 1778, 10.3390/ijerph6061778 Paty, 1988, MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT, Neurology, 38, 180, 10.1212/WNL.38.2.180 Kasivisvanathan, 2018, MRI-targeted or standard biopsy for prostate-cancer diagnosis, N. Engl. J. Med., 378, 1767, 10.1056/NEJMoa1801993 Wahsner, 2019, Chemistry of MRI contrast agents: current challenges and new frontiers, Chem. Rev., 119, 957, 10.1021/acs.chemrev.8b00363 Reynolds, 2000, Gadolinium-loaded nanoparticles: new contrast agents for magnetic resonance imaging, J. Am. Chem. Soc., 122, 8940, 10.1021/ja001426g Hingorani, 2015, A review of responsive MRI contrast agents: 2005-2014, Contrast Media Mol. Imaging, 10, 245, 10.1002/cmmi.1629 Yan, 2007, Magnetic resonance imaging contrast agents: overview and perspectives, Radiography, 13, e5, 10.1016/j.radi.2006.07.005 Na, 2009, Inorganic nanoparticles for MRI contrast agents, Adv. Mater., 21, 2133, 10.1002/adma.200802366 Viswanathan, 2010, Alternatives to gadolinium-based metal chelates for magnetic resonance imaging, Chem. Rev., 110, 2960, 10.1021/cr900284a Zhou, 2013, Gadolinium-based contrast agents for magnetic resonance cancer imaging, Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 5, 1, 10.1002/wnan.1198 Chan, 2007, Small molecular gadolinium (III) complexes as MRI contrast agents for diagnostic imaging, Coord. Chem. Rev., 251, 2428, 10.1016/j.ccr.2007.04.018 Yang, 2016, Gadolinium (iii) based nanoparticles for T 1-weighted magnetic resonance imaging probes, RSC Adv., 6, 60945, 10.1039/C6RA07782J Rogosnitzky, 2016, Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms, Biometals, 29, 365, 10.1007/s10534-016-9931-7 Guo, 2018, Gadolinium deposition in brain: current scientific evidence and future perspectives, Front. Mol. Neurosci., 11, 335, 10.3389/fnmol.2018.00335 Clough, 2019, Ligand design strategies to increase stability of gadolinium-based magnetic resonance imaging contrast agents, Nat. Commun., 10, 1420, 10.1038/s41467-019-09342-3 Gale, 2018, Gadolinium-free contrast agents for magnetic resonance imaging of the central nervous system, ACS Chem. Neurosci., 9, 395, 10.1021/acschemneuro.8b00044 Frullano, 2011, Strategies for the preparation of bifunctional gadolinium(III) chelators, Curr. Org. Synth., 8, 535, 10.2174/157017911796117250 Fatima, 2021, Recent advances in gadolinium based contrast agents for bioimaging applications, Nanomaterials, 11, 2449, 10.3390/nano11092449 Gizzatov, 2014, Geometrical confinement of Gd (DOTA) molecules within mesoporous silicon nanoconstructs for MR imaging of cancer, Cancer Lett., 352, 97, 10.1016/j.canlet.2014.06.001 Losic, 2015 Nissinen, 2014, Facile synthesis of biocompatible superparamagnetic mesoporous nanoparticles for imageable drug delivery, Microporous Mesoporous Mater., 195, 2, 10.1016/j.micromeso.2014.04.014 Sinha, 2017, Novel Gd-loaded silicon nanohybrid: a potential epidermal growth factor receptor expressing cancer cell targeting magnetic resonance imaging contrast agent, ACS Appl. Mater. Interfaces, 9, 42601, 10.1021/acsami.7b14538 Park, 2009, Biodegradable luminescent porous silicon nanoparticles for in vivo applications, Nat. Mater., 8, 331, 10.1038/nmat2398 Kumeria, 2017, Porous silicon for drug delivery applications and theranostics: recent advances, critical review and perspectives, Expet Opin. Drug Deliv., 14, 1407, 10.1080/17425247.2017.1317245 Tieu, 2019, Advances in porous silicon–based nanomaterials for diagnostic and therapeutic applications, Adv. Ther., 2 Park, 2019, Photoluminescent and biodegradable porous silicon nanoparticles for biomedical imaging, J. Mater. Chem. B, 7, 6271, 10.1039/C9TB01042D Oh, 2021, Thermally induced silane dehydrocoupling on porous silicon nanoparticles for ultra-long-acting drug release, Nanoscale, 13, 15560, 10.1039/D1NR03263A Kang, 2021, A deep dive: SIWV tetra-peptide enhancing the penetration of nanotherapeutics into the glioblastoma, ACS Biomater. Sci. Eng. Lees, 2003, Chemical stability of porous silicon surfaces electrochemically modified with functional alkyl species, Langmuir, 19, 9812, 10.1021/la035197y Qin, 2014, Size control of porous silicon nanoparticles by electrochemical perforation etching, part. Part, Syst. Charact., 31, 252, 10.1002/ppsc.201300244 Shirazi, 2021, SN38 loaded nanostructured lipid carriers (NLCs); preparation and in vitro evaluations against glioblastoma, J. Mater. Sci. Mater. Med., 32, 78, 10.1007/s10856-021-06538-2 Mortezazadeh, 2019, Gadolinium (III) oxide nanoparticles coated with folic acid-functionalized poly (β-cyclodextrin-co-pentetic acid) as a biocompatible targeted nano-contrast agent for cancer diagnostic: in vitro and in vivo studies, Magn. Reson. Mater. Phys. Biol. Med., 32, 487, 10.1007/s10334-019-00738-2 Wang, 2018, Self-reporting photoluminescent porous silicon microparticles for drug delivery, ACS Appl. Mater. Interfaces, 10, 3200, 10.1021/acsami.7b09071 Kang, 2016, Self-sealing porous silicon-calcium silicate core-shell nanoparticles for targeted siRNA delivery to the injured brain, Adv. Mater., 28, 7962, 10.1002/adma.201600634 Zhang, 2009, Gadolinium promoted proliferation and enhanced survival in human cervical carcinoma cells, Biometals, 22, 511, 10.1007/s10534-009-9208-5 Fry, 2014, Oxidation-Induced trapping of drugs in porous silicon microparticles, Chem. Mater., 26, 2758, 10.1021/cm500797b Xia, 2018, Co-loading of photothermal agents and anticancer drugs into porous silicon nanoparticles with enhanced chemo-photothermal therapeutic efficacy to kill multidrug-resistant cancer cells, Colloids Surf. B Biointerfaces, 164, 291, 10.1016/j.colsurfb.2018.01.059